 Don’t miss our top 5 cancer-related stories this month,
including a guest commentary from an industry leader, our two-part series on
trends in cancer research and more!
By E. Kevin Hrusovsky, PerkinElmer Inc. As the complexity and volume of data continue to rise, bioinformatics is emerging as one of the cornerstones of personalized medicine, from enabling discovery and development of novel treatments and diagnostics to facilitating collection, analysis and interpretation of data that ultimately helps an individual patient. SPECIAL REPORT PART 1: ‘Good enough’ is no longer good enough By Randall Willis, ddn Features Editor Aiming beyond the standard of care in oncology By Randall Willis, ddn Features Editor Are we really making things better for cancer patients? High-profile oncology partnership By Jim Cirigliano, ddn Contributing Editor Araxes Pharma and Janssen Biotech ink oncology drug development deal Natural neighbors By Kelsey Kaustinen, ddn Features Editor OSU, Biosortia link up to identify natural products for potential cancer treatments  |
 April 2013 The April Top 5 was sponsored by PerkinElmer. March 2013 The March Top 5 was sponsored by Olympus.
The October Top 5 was sponsored by Bio-Rad Laboratories. The September Top 5 was sponsored by Waters Corporation. The April Top 5 was sponsored by Bio-Rad Laboratories. The March Top 5 was sponsored by Bio-Rad Laboratories. The February Top 5 was sponsored by Bio-Rad Laboratories. The November Top 5 was sponsored by Rockland. The October Top 5 was sponsored by Rockland. The September Top 5 was sponsored by Rockland.
The April Top 5 was sponsored by Seahorse Bioscience and Trevigen, Inc.
The March Top 5 was sponsored by Seahorse Bioscience and Trevigen, Inc.
The February Top 5 was sponsored by Seahorse Bioscience and Trevigen, Inc.
|
       |
||
|
 
 
|
 |
© Copyright 2013 Old River Publications LLC. All righs reserved. | Web site managed and designed by OffWhite.